Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies-Reference-Cited by-同舟云学术

Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Published:2022-02 Issue:2 Volume:28 Page:88-95
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Gauntner Timothy D.^ORCID,Brunstein Claudio G.,Cao Qing,Weisdorf Daniel^ORCID,Warlick Erica D.,Jurdi Najla El,Maakaron Joseph E.^ORCID,Arora Mukta^ORCID,Betts Brian C.,Bachanova Veronika,Holtan Shernan G.,He Fiona C.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference28 articles.

1. Twenty-five years of peripheral blood stem cell transplantation;Körbling;Blood,2011

2. D'Souza A, Fretham C. Current use and outcomes of hematopoietic cell transplantation: CIBMTR US summary slides, 2019.

3. CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation

4. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation;Bittencourt;Blood,2002

5. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses;Ringdén;Br J Haematol,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF;Clinical and Experimental Medicine;2024-08-24

2. The health risk of social disadvantage is transplantable into a new host;Proceedings of the National Academy of Sciences;2024-07-15

3. Allogeneic hematopoietic stem cell transplant for familial hemophagocytic lymphohistiocytosis: a case report and literature review;Frontiers in Immunology;2024-06-03

4. High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality;Transfusion;2024-05

5. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients;Expert Opinion on Biological Therapy;2024-03-03